Answers are grounded in this paper and cite their sources.
A perquisite for achieving high COVID-19 vaccine uptake, not only among refugees and migrants but also in populations as a whole, is the ability of public health authorities to monitor and understand the emerging barriers and facilitators determining vaccine rollout.1 The study in The Lancet Healthy Longevity by Berthe Abi Zeid and colleagues2 is a welcome contribution to this demanding and challenging field of policy practice. Their research reports low COVID-19 vaccine uptake rates among Syrian refugees aged 50 years or older residing in Lebanon (1235 [42·5%] of 2906 participants interviewed up to March 14, 2022), and low vaccine acceptance rates among this vulnerable population group (38·1% of unvaccinated refugees were unwilling to receive the vaccine and 40·1% remained hesitant due to a fear of side-effects).
No takes yet. Share an insight, caveat, or question.
Kondilis et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: